The paradoxical benefit of sulfonylurea agents in diabetics undergoing coronary revascularization
Marso, S.P.; Topol, E.J.
European Heart Journal 19(11): 1601-1603
1998
ISSN/ISBN: 0195-668X PMID: 9857909 Document Number: 489233
Document emailed within 1 workday
Related Documents
Phed-on, U.; Naowapanich, S.; Poolsawat, U.; Nimmannit, A.; Wongpraparut, N. 2011: Benefit of post PCI medical checklist to improve adhering with best practice guidelines in the patients with coronary artery disease undergoing percutaneous coronary intervention (PCI) Journal of the Medical Association of Thailand 94 Suppl. 1: S1-10García-Guiral, M.; García del Valle, S.; Carrera, A.; Martínez, M.V.; Arribas, M.J.; Escarpa, A. 1994: Oral premedication with clonidine in patients undergoing coronary revascularization surgery Revista Espanola de Anestesiologia y Reanimacion 41(2): 82-88
Lee, M.S.; Rametta, S.; Aragon, J.; Khan, A.; Wilentz, J.; Singh, V.; Levitt, H.; Kamra, A.; Valania, G.; Makkar, R. 2005: New heparin dosing regimen for diabetics undergoing percutaneous coronary intervention Journal of Invasive Cardiology 17(5): 248-250
Zhang, Q.; Ma, C.-S.; Nie, S.-P. 2008: The impact of renal function on clinical outcomes of patients without chronic kidney disease undergoing coronary revascularization Zhonghua Nei Ke Za Zhi 47(9): 735-738
Fedele, D.; Tiengo, A.; Riva, F.; Muggeo, M.; Emanueli, A.; Crepaldi, G. 1972: Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea Arzneimittel-Forschung 22(11): 1885-1888
Safford, R.E. 1996: Coronary revascularization in the elderly: Florida multicenter consecutive case experience with coronary revascularization in patients age 75 years and older. The Program Committee Florida Chapter American College of Cardiology Comprehensive Therapy 22(8): 477-484
Lunetta, M.; Presti, C.; Mughini, M.T.; Mughini, L. 1980: Behavior of lactate and pyruvate in diabetics treated with a combination of fenformin and sulfonylurea in varying doses. i La Clinica Terapeutica 93(5): 525-533
Kaniak, J.; Kotschy, M.; Kurzawska, M.; Paczyńska, D. 1978: Blood coagulation, fibrinolysis and kallikreinogenesis in diabetics with vascular complications treated with insulin or sulfonylurea derivatives Polski Tygodnik Lekarski 33(27): 1065-1068
Maity, A.K.; Sen, A.K.; Chhetri, M.K. 1986: Profile of coronary problems in myocardial infarction in diabetics and non-diabetics Journal of the Indian Medical Association 84(2): 37-40
Davidson, M.B. 1987: Update on therapy of diabetes mellitus: diet, sulfonylurea agents, and insulin Mount Sinai Journal of Medicine new York 54(3): 199-210
Batyraliev, T.A.; Fetser, D.V.; Preobrazhenskiĭ, D.V.; Pershukov, I.V.; Akylbekov, M.; Belenkov, I.N. 2010: Optimal method of revascularization in patients with multivessel coronary artery involvement for application of drug eluting stents: percutaneous coronary interventions in comparison with coronary bypassing Kardiologiia 50(2): 84-90
Fujimoto, Y.; Ishiwata, S.; Dohi, T.; Masuda, J.; Fujimoto, H.; Mitani, H.; Maehara, A.; Ohno, M.; Yamaguchi, T.; Tanaka, K.; Naruse, Y. 2007: Long-term prognosis after coronary revascularization in patients with end-stage renal disease on dialysis: comparison of percutaneous coronary intervention and coronary artery bypass grafting Journal of Cardiology 50(1): 11-20
Ricci, S.; Cenciarelli, S.; Mazzoli, T.; Barilaro, A.; Mattioni, A. 2009: The benefit of revascularization in asymptomatic patients is rather poor Giornale Italiano di Cardiologia 10(10): 668-669; Discussion 670
Cormier, J.M.; Ricco, J.B.; Varron, F.; Laurian, C.; Gigou, F.; Fichelle, J.M. 1985: Limitations and results of revascularization of the lower extremities of diabetics Journal des Maladies Vasculaires 10(4): 287-290
Vannasaeng, S.; Ploybutr, S.; Nitiyanant, W.; Peerapatdit, T.; Vichayanrat, A. 1995: Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus Journal of the Medical Association of Thailand 78(11): 578-585
Guron, G.; Jönsson, K.Z.; Saeed, A.; Nowakowska-Fortuna, E.; Jensen, G.; Herlitz, H. 2012: Atherosclerotic renal artery stenosis: Revascularization is of benefit--on the right patient and on the correct indication Lakartidningen 109(29-31): 1354-1355
Metzger, J.P.; Bor, J.; Rojano-Guzman, A.; Gambini, D.; Vacheron, A.; de Vernejoul, P.; Di Mattéo, J. 1980: Induced coronary spasm: immediate revascularization by the opposite coronary artery. use of myocardial scintigraphy Archives des Maladies du Coeur et des Vaisseaux 73(3): 307-312
Mehta, R.H.; Sketch, M.H. 2004: Percutaneous coronary revascularization in diabetic patients with multivessel coronary artery disease: importance and feasibility Journal of Invasive Cardiology 16(3): 107-108
Agarwal, A.K.; Singla, S.; Singla, S.; Singla, R.; Lal, A.; Wardhan, H.; Yadav, R. 2009: Prevalence of coronary risk factors in type 2 diabetics without manifestations of overt coronary heart disease Journal of the Association of Physicians of India 57(1): 135-142
Agayev, M.M. 2014: Clinical Perspectives of Complex Application of Percutaneous Coronary Intervention and Drug Revascularization in Acute Coronary Syndrome Likars'ka Sprava 2014(9-10): 46-56